14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.41 $2.35 Thursday, 25th Apr 2024 CYCC stock ended at $1.60. This is 30.43% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 40.93% from a day low at $1.41 to a day high of $1.99.
90 days $1.41 $3.08
52 weeks $1.41 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Nov 30, 2023 $5.00 $6.00 $4.20 $4.50 155 909
Nov 29, 2023 $4.50 $4.79 $4.22 $4.46 9 227
Nov 28, 2023 $4.65 $4.80 $4.21 $4.47 11 135
Nov 27, 2023 $4.70 $4.93 $4.06 $4.34 5 995
Nov 24, 2023 $4.07 $4.64 $4.05 $4.64 4 153
Nov 22, 2023 $4.50 $4.50 $3.99 $4.20 14 588
Nov 21, 2023 $4.37 $4.37 $4.05 $4.07 7 661
Nov 20, 2023 $4.65 $4.70 $4.20 $4.50 17 808
Nov 17, 2023 $5.25 $5.25 $4.31 $4.53 28 886
Nov 16, 2023 $5.25 $5.70 $5.25 $5.27 8 002
Nov 15, 2023 $5.10 $5.70 $4.80 $5.19 18 583
Nov 14, 2023 $7.50 $7.84 $4.13 $5.03 34 672
Nov 13, 2023 $8.66 $8.66 $7.68 $7.81 6 910
Nov 10, 2023 $8.10 $8.83 $8.03 $8.12 9 264
Nov 09, 2023 $9.00 $9.69 $8.10 $8.70 4 223
Nov 08, 2023 $9.11 $9.11 $8.40 $8.67 3 414
Nov 07, 2023 $9.00 $9.60 $8.80 $8.80 2 393
Nov 06, 2023 $9.00 $10.12 $9.00 $9.50 11 170
Nov 03, 2023 $8.40 $9.00 $7.59 $8.72 7 999
Nov 02, 2023 $9.13 $9.13 $8.32 $8.78 4 749
Nov 01, 2023 $8.38 $9.13 $8.32 $8.93 7 955
Oct 31, 2023 $8.10 $8.68 $7.65 $8.08 4 314
Oct 30, 2023 $8.43 $9.30 $8.42 $8.42 4 711
Oct 27, 2023 $8.49 $9.30 $8.48 $8.48 5 612
Oct 26, 2023 $8.02 $8.31 $7.95 $8.26 4 576
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT